1
|
Abstract
Preexposure prophylaxis (PrEP) is increasingly implemented in national HIV prevention programmes through routine care. Monitoring will be vital to understand whether programmes succeed in engaging people into using PrEP appropriately, and in reducing the HIV epidemic. Yet, it is currently unclear which indicators are most suited to monitor PrEP programmes' performance. We therefore aimed to identify and map indicators that are currently used or suggested for monitoring PrEP programmes. We conducted a scoping review based on the framework by Arksey and O'Malley. We combined a systematic search in the peer-reviewed literature with hand-searching grey literature documents describing indicators and strategies that are used or suggested for PrEP monitoring. Only literature published after 2012 was included. No geographical restrictions were set. We charted data on indicator definitions, data sources used, reported experiences with monitoring and any relevant contextual factors. Ultimately, 35 peer-reviewed and 14 grey literature records were included. We identified indicators related to preuptake stages of PrEP, uptake and coverage, and programme impact. The indicators most commonly suggested for national-level monitoring were the number of new and current PrEP users, the number of HIV seroconversions among PrEP users and some variably defined indicators related to continuation and discontinuation of PrEP. Despite its perceived high relevance, studies reported several challenges to routinely monitor the population in need of PrEP and track prevention-effective PrEP use. In conclusion, a variety of indicators is currently used or suggested for monitoring PrEP programmes. Implementing proxy measures that track different aspects of PrEP use over time, and making synergies with research more explicit, could be used as strategies to obtain more granular insights into trends revealed by routine monitoring.
Collapse
|
2
|
Myers JE, Edelstein ZR, Daskalakis DC, Gandhi AD, Misra K, Rivera AV, Salcuni PM, Scanlin K, Udeagu CC, Braunstein SL. Preexposure Prophylaxis Monitoring in New York City: A Public Health Approach. Am J Public Health 2019; 108:S251-S257. [PMID: 30383427 DOI: 10.2105/ajph.2018.304729] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
The scale-up of preexposure prophylaxis (PrEP) represents a paradigm shift in HIV prevention that poses unique challenges for public health programs. Monitoring of PrEP implementation at the population level is a national priority, with particular significance in New York City (NYC) given the substantial HIV burden and the prominence of PrEP in state and local Ending the Epidemic program plans. We highlight the importance of local monitoring and evaluation of PrEP implementation outcomes and describe the experience at the NYC Health Department, which includes engaging communities, triangulating a variety of data sources regarding PrEP implementation, and leveraging those data to help guide programming. In NYC, we used data from national surveillance systems and incorporated PrEP-related indicators into existing local data collection systems to help illustrate gaps in PrEP awareness and use. Ultimately, ensuring that PrEP achieves the desired impact at the population level depends on identifying disparities through appropriate and accurate measurement, and addressing them through evidence-based programs.
Collapse
Affiliation(s)
- Julie E Myers
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Zoe R Edelstein
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Demetre C Daskalakis
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Anisha D Gandhi
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Kavita Misra
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Alexis V Rivera
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Paul M Salcuni
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Kathleen Scanlin
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Chi-Chi Udeagu
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| | - Sarah L Braunstein
- Julie E. Myers, Zoe R. Edelstein, Anisha D. Gandhi, Kavita Misra, Alexis V. Rivera, Paul M. Salcuni, Kathleen Scanlin, Chi-Chi Udeagu, and Sarah L. Braunstein are with the Bureau of HIV/AIDS Prevention and Control, New York City Department of Health and Mental Hygiene (DOHMH), Queens, NY. Demetre C. Daskalakis is with the Division of Disease Control, New York City Department of Health and Mental Hygiene
| |
Collapse
|
4
|
Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States. AIDS 2018; 32:407-417. [PMID: 29381558 DOI: 10.1097/qad.0000000000001733] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
: The current review re-conceptualizes seek and test strategies, particularly given the changing importance of HIV testing as care continuum entry for persons irrespective of their HIV status. Care continuum entry advances previous seek and test strategies for client engagement with two next-generation functions: use of testing to engage (or re-engage) HIV negative clients in preexposure prophylaxis (PrEP) care; and testing individuals who may already be known positives for care continuum re-entry. We review existing seek and test strategies for most impacted community members with a goal of optimizing care continuum entry as we move towards HIV transmission elimination. These strategies are context, sub-group, community and epidemic-specific. This review is timely, given the initiation of routine PrEP care, which shifts and broadens our conceptualization of care continuum entry triggered by the HIV testing event. In addition, as the epidemic becomes more concentrated, focusing on re-engagement of HIV-infected persons becomes increasingly important given that transmission events involve both those acutely and newly infected as well as the large numbers who may not be virally suppressed. We start with examination of routine testing in healthcare settings, emphasizing its potential role in re-engagement for persons out of care. Subsequently, we describe risk-based testing to identify key populations. We then review network-based approaches and their impact on the epidemic. We close with future directions for individual and combination care continuum entry strategies most relevant to elimination of HIV transmission in the United States.
Collapse
|
5
|
Herbst JH, Raiford JL, Carry MG, Wilkes AL, Ellington RD, Whittier DK. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men. MMWR Suppl 2016; 65:42-50. [PMID: 26916033 DOI: 10.15585/mmwr.su6501a7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
CDC's high-impact human immunodeficiency virus (HIV) prevention approach calls for targeting the most cost-effective and scalable interventions to populations of greatest need to reduce HIV incidence. CDC has funded research to adapt and demonstrate the efficacy of Personalized Cognitive Counseling (PCC) as an HIV prevention intervention. Project ECHO, based in San Francisco, California, during 2010-2012, involved an adaptation of PCC for HIV-negative episodic substance-using men who have sex with men (SUMSM) and a randomized trial to test its efficacy in reducing sexual and substance-use risk behaviors. Episodic substance use is the use of substances recreationally and less than weekly. PCC is a 30-minute to 50-minute counseling session that involves addressing self-justifications men use for engaging in risky sexual behavior despite knowing the potential for HIV infection. By exploring these justifications, participants become aware of the ways they make sexual decisions, become better prepared to realistically assess their risk for HIV during future risky situations, and make decisions to decrease their HIV risk. The findings of Project ECHO demonstrated the efficacy of PCC for reducing HIV-related substance-use risk behaviors. The study also demonstrated efficacy of PCC for reducing sexual risk behaviors among SUMSM screened as nondependent on targeted drug substances. CDC has identified PCC as a "best evidence" HIV behavioral intervention and supports its national dissemination. Several features of PCC enhance its feasibility of implementation: it is brief, delivered with HIV testing, relatively inexpensive, allows flexibility in counselor qualifications and delivery settings, and is individualized to each client. The original PCC and its adapted versions can contribute to reducing HIV-related health disparities among high-risk MSM, including substance users, by raising awareness of and promoting reductions in personal risk behaviors.
Collapse
|
6
|
Castel AD, Magnus M, Greenberg AE. Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future. Infect Dis Clin North Am 2014; 28:563-83. [PMID: 25455314 DOI: 10.1016/j.idc.2014.08.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
This article presents an overview of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) prevention. The authors describe the past animal and human research that has been conducted that informs our current understanding of PrEP; summarize ongoing research in the area, including describing new regimens and delivery mechanisms being studied for PrEP; and highlight key issues that must be addressed in order to implement and optimize the use of this HIV prevention tool.
Collapse
Affiliation(s)
- Amanda D Castel
- Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, Northwest, 5th Floor, Washington, DC 20052, USA.
| | - Manya Magnus
- Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, Northwest, 5th Floor, Washington, DC 20052, USA
| | - Alan E Greenberg
- Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Avenue, Northwest, 5th Floor, Washington, DC 20052, USA
| |
Collapse
|